Fig. 1

Chemical structures of the three drugs coadminstered for treatment of Parkinson’s disease; LD (A), CD monohydrate (B) and ENT (C)
Chemical structures of the three drugs coadminstered for treatment of Parkinson’s disease; LD (A), CD monohydrate (B) and ENT (C)